Aandeel 000919 JINLING PHARMACEUTICAL COMPANY LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Jinling Pharmaceutical Company Limited

Aandelen

000919

CNE0000010W5

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 20-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
7,17 CNY +0,28% Intraday-grafiek van Jinling Pharmaceutical Company Limited -0,69% -8,89%
29/04 Jinling Pharmaceutical Company Limited rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 CI
18/04 Jinling Pharmaceutical Company Limited rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2023
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
Hefei Jinling Tianyi Smart Elderly Care Services Co., Ltd. announced that it expects to receive CNY 600 million in funding from Jinling Pharmaceutical Company Limited
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Jinling Pharmaceutical Company Limited announced that it has received CNY 749.999998 million in funding from a group of investors
Jinling Pharma in Talks to Buy Over 50% Stake in Local Hospital
Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Jinling Pharma Selling 750 Million Yuan Shares to Fund New Projects
Jinling Pharmaceutical Company Limited Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 14 July 2023
Jinling Pharmaceutical Company Limited Approves Management Appointments
Jinling Pharmaceutical Company Limited Approves Cash Dividend for the Year 2022
Jinling Pharmaceutical Vice Chairman Resigns
Jinling Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Jinling Pharmaceutical Company Limited Proposes Final Cash Dividend for the Year 2022
Jinling Pharmaceutical Company Limited announced that it expects to receive CNY 750 million in funding from Nanjing New Industrial Investment Group Co., Ltd and other investors
Jinling Pharma Gets 155 Million Yuan Compensation for Office Demolition, Relocation
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022
Jinling Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 000919
  4. Nieuws Jinling Pharmaceutical Company Limited
  5. Andere talen